Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease

Background: Recent evidence has indicated that beta-secretase 1 (BACE1) is involved in the production of amyloid beta (Aβ) in patients affected with Alzheimer’s disease (AD). Therefore; the purpose of this study was to measure mRNA and plasma levels of BACE1 in AD patients, as an early diagnosis bio...

Full description

Bibliographic Details
Main Authors: Alireza Vakilian, Javad Masoumi, Saeid Mirzaee, Hossein Khorramdelazad
Format: Article
Language:English
Published: Babol University of Medical Sciences 2019-06-01
Series:Caspian Journal of Internal Medicine
Subjects:
Online Access:http://caspjim.com/article-1-1635-en.html
_version_ 1828838992587522048
author Alireza Vakilian
Javad Masoumi
Saeid Mirzaee
Hossein Khorramdelazad
author_facet Alireza Vakilian
Javad Masoumi
Saeid Mirzaee
Hossein Khorramdelazad
author_sort Alireza Vakilian
collection DOAJ
description Background: Recent evidence has indicated that beta-secretase 1 (BACE1) is involved in the production of amyloid beta (Aβ) in patients affected with Alzheimer’s disease (AD). Therefore; the purpose of this study was to measure mRNA and plasma levels of BACE1 in AD patients, as an early diagnosis biomarker for such individuals. Methods: A total number of thirty AD patients and thirty normal subjects as controls were recriuted in the present study. Plasma levels of BACE1 were then examined via enzyme-linked immunosorbent assay (ELISA) and also mRNA expression of BACE1 in total blood was measured using real-time PCR technique. Results: The findings revealed a significant difference in gene expression of BACE1 in the peripheral blood of AD patients compared with that in controls (p<0.0001). Additionally, elevated plasma levels of BACE1 were found in AD patients compared with those in normal subjects (p<0.01). Statistical analyses also demonstrated no correlation between expression (mRNA and protein) of BACE1 in both AD patients and controls and age or the results of Mini-Mental State Examination (MMSE) scale (p>0.05). Conclusion: Given the importance of early diagnosis of AD patients, it was suggested that the measurement of plasma levels and also mRNA expression of BACE1 might be a valuable blood-based biomarker used in preference to other invasive diagnostic methods such as cerebrospinal fluid (CSF) analysis.
first_indexed 2024-12-12T19:14:09Z
format Article
id doaj.art-4b77eb7b6a534d4799f99f1738b6dd47
institution Directory Open Access Journal
issn 2008-6164
2008-6172
language English
last_indexed 2024-12-12T19:14:09Z
publishDate 2019-06-01
publisher Babol University of Medical Sciences
record_format Article
series Caspian Journal of Internal Medicine
spelling doaj.art-4b77eb7b6a534d4799f99f1738b6dd472022-12-22T00:14:45ZengBabol University of Medical SciencesCaspian Journal of Internal Medicine2008-61642008-61722019-06-01103276280Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s diseaseAlireza Vakilian0Javad Masoumi1Saeid Mirzaee2Hossein Khorramdelazad3 Non Communicable Diseases Research Center, Rafsanjan University of Medical Science, Rafsanjan, Iran Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran Background: Recent evidence has indicated that beta-secretase 1 (BACE1) is involved in the production of amyloid beta (Aβ) in patients affected with Alzheimer’s disease (AD). Therefore; the purpose of this study was to measure mRNA and plasma levels of BACE1 in AD patients, as an early diagnosis biomarker for such individuals. Methods: A total number of thirty AD patients and thirty normal subjects as controls were recriuted in the present study. Plasma levels of BACE1 were then examined via enzyme-linked immunosorbent assay (ELISA) and also mRNA expression of BACE1 in total blood was measured using real-time PCR technique. Results: The findings revealed a significant difference in gene expression of BACE1 in the peripheral blood of AD patients compared with that in controls (p<0.0001). Additionally, elevated plasma levels of BACE1 were found in AD patients compared with those in normal subjects (p<0.01). Statistical analyses also demonstrated no correlation between expression (mRNA and protein) of BACE1 in both AD patients and controls and age or the results of Mini-Mental State Examination (MMSE) scale (p>0.05). Conclusion: Given the importance of early diagnosis of AD patients, it was suggested that the measurement of plasma levels and also mRNA expression of BACE1 might be a valuable blood-based biomarker used in preference to other invasive diagnostic methods such as cerebrospinal fluid (CSF) analysis.http://caspjim.com/article-1-1635-en.htmlBACE1Alzheimer’s diseasebiomarker
spellingShingle Alireza Vakilian
Javad Masoumi
Saeid Mirzaee
Hossein Khorramdelazad
Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
Caspian Journal of Internal Medicine
BACE1
Alzheimer’s disease
biomarker
title Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
title_full Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
title_fullStr Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
title_full_unstemmed Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
title_short Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
title_sort expression analysis of beta secretase 1 bace1 enzyme in peripheral blood of patients with alzheimer s disease
topic BACE1
Alzheimer’s disease
biomarker
url http://caspjim.com/article-1-1635-en.html
work_keys_str_mv AT alirezavakilian expressionanalysisofbetasecretase1bace1enzymeinperipheralbloodofpatientswithalzheimersdisease
AT javadmasoumi expressionanalysisofbetasecretase1bace1enzymeinperipheralbloodofpatientswithalzheimersdisease
AT saeidmirzaee expressionanalysisofbetasecretase1bace1enzymeinperipheralbloodofpatientswithalzheimersdisease
AT hosseinkhorramdelazad expressionanalysisofbetasecretase1bace1enzymeinperipheralbloodofpatientswithalzheimersdisease